Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis

Camille V Edwards, MD, Julia Gould, BA, Arielle L Langer, MD MPH, Markus Mapara, MD PhD, Jai Radhakrishnan, MD, Matthew S Maurer, MD, Shahzad Raza, MD, John G Mears, MD, Jonathan S Wall, PhD, Alan Solomon, MD, Suzanne Lentzsch, MD PhD

Blood (2016) 128 (22): 643.

https://doi.org/10.1182/blood.V128.22.643.643

Published: 2016

Journal Articles

Interferon-Gamma Signaling in the Pathogenesis of Idiopathic Pneumonia Syndrome Following Allogeneic Bone Marrow Transplantation

Hui-Hui Ma, PhD, Biin Sung, MS, Caisheng Lu, MDPhD, Liangsong Song, MDPhD, Rika Gomi, MDPhD, Wenzhu Wu, BS, Jing Fu, PhD, Suzanne Lentzsch, MD PhD, Stefan Worgall, MDPhD, Markus Mapara, MD PhD

Blood (2015) 126 (23): 3075.

https://doi.org/10.1182/blood.V126.23.3075.3075

Published: 2015

Journal Articles

Mechanism Study of Matrix Metalloproteinase 13 Effects on Osteoclast Activation and Lytic Bone Lesions in Multiple Myeloma

Jing Fu, PhD, Shirong Li, PhD, G. David Roodman, MD PhD, Markus Mapara, MD PhD, Stephen J. Weiss, MD, Suzanne Lentzsch, MD PhD

Blood (2015) 126 (23): 3009.

https://doi.org/10.1182/blood.V126.23.3009.3009

Published: 2015

Journal Articles

Results of Phase I Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis

Arielle L Langer, MD MPH, Susanna Miao, Markus Mapara, MD PhD, Jai Radhakrishnan, MD, Mathew S. Maurer, MD, Shahzad Raza, MD, John G. Mears, MD, Alan Solomon, MD, Suzanne Lentzsch, MD PhD

Blood (2015) 126 (23): 188.

https://doi.org/10.1182/blood.V126.23.188.188

Published: 2015

Journal Articles

Pomalidomide Induces Mir-125b with Subsequent Downregulation of P53 in CD34 + cells Conferring Decreased Apoptosis: A Potential Mechanism of Secondary Primary Malignancies

Yijie Zheng, PhD, Shirong Li, PhD, Jing Fu, PhD, Markus Mapara, MD PhD, Suzanne Lentzsch, MD PhD

Blood (2014) 124 (21): 3437.

https://doi.org/10.1182/blood.V124.21.3437.3437

Published: 2014

Journal Articles

IMiD® Compounds Affect the Hematopoiesis Via CRBN Dependent Degradation of IKZF1 Protein in CD34 + Cells

Shirong Li, PhD, Jing Fu, PhD, Markus Mapara, MD PhD, Suzanne Lentzsch, MD PhD

Blood (2014) 124 (21): 418.

https://doi.org/10.1182/blood.V124.21.418.418

Published: 2014

Journal Articles

IFN-γ/STAT1-Dependent Regulation Of Antigen Presenting Cell (APC) Function: Role In Graft-Versus-Host Disease (GVHD)

Caisheng Lu, PHD, Huihui Ma, PhD, Shirong Li, PhD, Suzanne Lentzsch, MD, PhD, Markus Mapara, MD, PhD

Blood (2013) 122 (21): 3252.

https://doi.org/10.1182/blood.V122.21.3252.3252

Published: 2013

Journal Articles

Lenalidomide and Dexamethasone Alone Is Equivalent To Lenalidomide and Dexamethasone With Autologous Stem Cell Transplant In Newly Diagnosed Multiple Myeloma: Interim Study Results Of a Randomized Trial

Jordan M. Schecter, MD, Kristen Kipps, MD, Amy O'Sullivan, BS, BSN, MSW, Kent A. Griffith, MPH, MS, Daniel Normolle, PhD, Markus Mapara, MD, PhD, Robert Redner, MD, Suzanne Lentzsch, MD, PhD

Blood (2013) 122 (21): 3180.

https://doi.org/10.1182/blood.V122.21.3180.3180

Published: 2013

Journal Articles

Overexpression of Eukaryotic Initiation Factor 4E Induces Critical Transcription Factors Such As c-Myc in Multiple Myeloma Resulting in Enhanced Clonogenic Tumor Growth in Vitro and in Vivo .

Shirong Li, PhD, Jing Fu, Ph D, Jordan M. Schecter, MD, BS, Caisheng Lu, PhD, Markus Mapara, MD PhD, Suzanne Lentzsch, MD, PhD

Blood (2012) 120 (21): 2908.

https://doi.org/10.1182/blood.V120.21.2908.2908

Published: 2012

Journal Articles

Matrix Metalloproteinase 13 (MMP13) Upregulation Is Essential for Multiple Myeloma Related Bone Lytic Lesion

Jing Fu, Ph D, Shirong Li, PhD, Rentian Feng, PhD, Huihui Ma, PhD, Farideh Sabeh, PhD, G David Roodman, MD, PhD, Markus Mapara, MD PhD, Stephen J Weiss, MD, Suzanne Lentzsch, MD, PhD

Blood (2012) 120 (21): 4025.

https://doi.org/10.1182/blood.V120.21.4025.4025

Published: 2012

Journal Articles

IL-12 hi Rapamycin-Conditioned Dendritic Cells Mediate IFN-γ-Dependent Apoptosis of Alloreactive CD4 + T Cells and Limit Graft-Versus-Host Diseas

Elizabeth O. Stenger, MD, Brian R. Rosborough, BS, Lisa Mathews, BS, Huihui Ma, Markus Mapara, MD PhD, Angus W. Thomson, PhD, Heth R. Turnquist, PhD

Blood (2012) 120 (21): 4110.

https://doi.org/10.1182/blood.V120.21.4110.4110

Published: 2012

Journal Articles

Immunomodulatory Derivatives of Thalidomide (IMiD)-Induced Neutropenia Is Associated with PU.1 Downregulation and Myeloid Maturation Arrest

Rekha Pal, G. David Roodman, MD, PhD, Markus Mapara, MD, PD, Lynn Mocsinski, MD, Alan F List, MD, Suzanne Lentzsch, MD, PhD

Blood (2008) 112 (11): 845.

https://doi.org/10.1182/blood.V112.11.845.845

Published: 2008

Journal Articles

Nocodazole Induces Myeloma Cell Death by Disrupting the Microtubular Network, Resulting in G2/M Arrest

Rentian Feng, PhD, Jorge A Rios, MD, Markus Mapara, MD, PD, Suzanne Lentzsch, MD, PhD

Blood (2008) 112 (11): 3673.

https://doi.org/10.1182/blood.V112.11.3673.3673

Published: 2008

Journal Articles

Cucurbitacin I (JSI-124) Has Potent Anti-Myeloma Effects Independent of Its Inhibition of JAK2-Induced STAT3 Activation.

Huihui Ma, MD, PhD, Judith Ziegler, BS, CMT, Ren-Tien Feng, PhD, Suzanne Lentzsch, MD, PhD, Markus Mapara, MD, PhD

Blood (2007) 110 (11): 2521.

https://doi.org/10.1182/blood.V110.11.2521.2521

Published: 2007

Journal Articles

Chronic Graft Versus Host Disease and Pretransplant Disease Status Predict Outcomes in Patients with Hematologic Malignancies Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation.

Megha A. Shah, BA, BS, Mounzer Agha, MD, Markus Mapara, MD, Kate Lenhart, Anastasios Raptis, MD

Blood (2007) 110 (11): 5090.

https://doi.org/10.1182/blood.V110.11.5090.5090

Published: 2007

Journal Articles

Inhibition of Graft-Versus-Host-Disease (GVHD) by Treatment with the Cyclopentenone Prostaglandin 15d-PGJ2 Involves Modulation of the NF-κB Signaling Pathway.

Huihui Ma, MD, PhD, Judith Ziegler, BS, CMT, Suzanne Lentzsch, MD, PhD, Markus Mapara, MD, PhD

Blood (2007) 110 (11): 3238.

https://doi.org/10.1182/blood.V110.11.3238.3238

Published: 2007

Journal Articles

Risk Factors for BK Viruria and Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplant (HSCT) Recipients.

Wassim McHayleh, MD, Rajesh Sehgal, MD, Walid El-Ayass, MD, Shahid Husain, MD, Parmjeet Randhawa, MD, Michael Boyiadzis, MD, MHSc, Anastasios Raptis, MD, Mounzer Agha, MD, Markus Mapara, MD, PhD

Blood (2007) 110 (11): 1072.

https://doi.org/10.1182/blood.V110.11.1072.1072

Published: 2007

Journal Articles

Cologne High-Dose Sequential Chemotherapy in Relapsed and Refractory Hodgkin Lymphoma - Results of a Large Multicenter Study of the German Hodgkin Lymphoma Study Group (GHSG).

Andreas Josting, MD, Christian Rudolph, MD, Markus Mapara, MD, Jan-Peter Glossmann, MD, Markus Sieber, MD, Hartmut H. Kirchner, MD, Bernd Dörken, MD, Dieter K. Hossfeld, MD, Jens Kisro, MD, Bernd Metzner, MD, Wolfgang E. Berdel, MD, Volker Diehl, MD, Andreas Engert, MD

Blood (2004) 104 (11): 309.

https://doi.org/10.1182/blood.V104.11.309.309

Published: 2004

NARROW

Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis

Interferon-Gamma Signaling in the Pathogenesis of Idiopathic Pneumonia Syndrome Following Allogeneic Bone Marrow Transplantation

Mechanism Study of Matrix Metalloproteinase 13 Effects on Osteoclast Activation and Lytic Bone Lesions in Multiple Myeloma

Results of Phase I Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis

Pomalidomide Induces Mir-125b with Subsequent Downregulation of P53 in CD34 + cells Conferring Decreased Apoptosis: A Potential Mechanism of Secondary Primary Malignancies

IMiD® Compounds Affect the Hematopoiesis Via CRBN Dependent Degradation of IKZF1 Protein in CD34 + Cells

IFN-γ/STAT1-Dependent Regulation Of Antigen Presenting Cell (APC) Function: Role In Graft-Versus-Host Disease (GVHD)

Lenalidomide and Dexamethasone Alone Is Equivalent To Lenalidomide and Dexamethasone With Autologous Stem Cell Transplant In Newly Diagnosed Multiple Myeloma: Interim Study Results Of a Randomized Trial

Overexpression of Eukaryotic Initiation Factor 4E Induces Critical Transcription Factors Such As c-Myc in Multiple Myeloma Resulting in Enhanced Clonogenic Tumor Growth in Vitro and in Vivo .

Matrix Metalloproteinase 13 (MMP13) Upregulation Is Essential for Multiple Myeloma Related Bone Lytic Lesion

IL-12 hi Rapamycin-Conditioned Dendritic Cells Mediate IFN-γ-Dependent Apoptosis of Alloreactive CD4 + T Cells and Limit Graft-Versus-Host Diseas

Immunomodulatory Derivatives of Thalidomide (IMiD)-Induced Neutropenia Is Associated with PU.1 Downregulation and Myeloid Maturation Arrest

Nocodazole Induces Myeloma Cell Death by Disrupting the Microtubular Network, Resulting in G2/M Arrest

Cucurbitacin I (JSI-124) Has Potent Anti-Myeloma Effects Independent of Its Inhibition of JAK2-Induced STAT3 Activation.

Chronic Graft Versus Host Disease and Pretransplant Disease Status Predict Outcomes in Patients with Hematologic Malignancies Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation.

Inhibition of Graft-Versus-Host-Disease (GVHD) by Treatment with the Cyclopentenone Prostaglandin 15d-PGJ2 Involves Modulation of the NF-κB Signaling Pathway.

Risk Factors for BK Viruria and Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplant (HSCT) Recipients.

Cologne High-Dose Sequential Chemotherapy in Relapsed and Refractory Hodgkin Lymphoma - Results of a Large Multicenter Study of the German Hodgkin Lymphoma Study Group (GHSG).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only